Table 3.
Inhibitor | In vitro efficacy (EC50, mM) | Cytotoxicity (TC50, mM) |
Safety Interval (TC50/EC50) | |||
---|---|---|---|---|---|---|
2DG | 0.54 | 36.0 | 66.7 | |||
2DG6P | 18.0 | >72.0 | >4.0 | |||
2FDG | 0.30 | >72.0 | >240 |
Inhibitor | In vitro efficacy (EC50, mM) | Cytotoxicity (TC50, mM) |
Safety Interval (TC50/EC50) | |||
---|---|---|---|---|---|---|
2DG | 0.54 | 36.0 | 66.7 | |||
2DG6P | 18.0 | >72.0 | >4.0 | |||
2FDG | 0.30 | >72.0 | >240 |